About aflo
aflo™ teaches you to inhale your medicines correctly and uses data about your inhaler interactions and air quality to help you to manage your condition.
Supported by funding from Innovate UK, Invest NI, QUBIS, Ulster University and angel investors, we have co-designed and built a hyper-personalised ‘smart inhaler’ for improved self management & quantified remote monitoring.
Meet the team
Dr Susan Kelly
CEO and Co-founder
Susan brings over fifteen years experience in Market Access/ Managed Entry for new medicines in the UK healthcare sector. Prior to forming Respiratory Analytics in 2019, to develop aflo™, she held a series of roles focused on the development of digital respiratory solutions.
Prof Liam McDaid
R&D Head and Co-founder
Liam cofounded Respiratory Analytics and leads the machine learning algorithm development, training, testing and deployment for aflo™
Dr Jim Harkin
CTO and Co-founder
Respiratory Analytics cofounder Dr Jim Harkin focuses on electronics design, manufacture and translation of the machine learning algorithm to the embedded device.
Dr Martin Kelly
Clinical Lead
Dr Martin Kelly worked in Christchurch, New Zealand before becoming a consultant respiratory physician at Altnagelvin Hospital in 2004. Martin works on a number of EU wide asthma and COPD studies and has expertise in inhaler device technology.
Dr Jack Cochran
US advisor
Investor and former Executive Director (CEO) of the Permanente Federation of Kaiser Permanente, (2007-15) during a period of major innovation in care delivery and improvement in clinical quality. Listed in the top 50 U.S. Physician Leaders in 2009, 2010, and 2012.
Ryan Williams
Chair & lead investor
Ryan Williams is a tech entrepreneur and angel investor. Co-founder Connected Health & The Amp with 25 years founding & scaling businesses.
